ALXN
Alexion Pharmaceuticals
ALXN
ALXN
Delisted
ALXN was delisted on the 20th of July, 2021.
595 hedge funds and large institutions have $30B invested in Alexion Pharmaceuticals in 2017 Q3 according to their latest regulatory filings, with 88 funds opening new positions, 218 increasing their positions, 214 reducing their positions, and 45 closing their positions.
New
Increased
Maintained
Reduced
Closed
more first-time investments, than exits
New positions opened: | Existing positions closed:
more call options, than puts
Call options by funds: $ | Put options by funds: $
more capital invested
Capital invested by funds: $ → $
more funds holding
Funds holding: →
2% more repeat investments, than reductions
Existing positions increased: 218 | Existing positions reduced: 214
0% more funds holding in top 10
Funds holding in top 10: 19 → 19 (0)
Holders
595
Holding in Top 10
19
Calls
$551M
Puts
$435M
Top Buyers
| 1 | +$657M | |
| 2 | +$121M | |
| 3 | +$86.4M | |
| 4 |
UBS AM
Chicago,
Illinois
|
+$71.3M |
| 5 |
Alkeon Capital Management
New York
|
+$70.1M |
Top Sellers
| 1 | -$339M | |
| 2 | -$220M | |
| 3 | -$189M | |
| 4 |
State Street
Boston,
Massachusetts
|
-$85M |
| 5 |
BlackRock
New York
|
-$79.8M |